AI Article Synopsis
- - Hepatic tuberculosis (TB) is a rare form of TB that affects the liver, often seen in patients with weakened immune systems, like those on immunosuppressive drugs or with HIV.
- - Primary cases of hepatic TB are uncommon; it usually occurs as a result of TB spreading from other parts of the body via lymphatics or blood vessels.
- - The report discusses a specific case of hepatic TB in a patient who was treated with adalimumab for ankylosing spondylitis, highlighting the connection between immunosuppressive therapy and the development of this condition.
Article Abstract
Hepatic tuberculosis (TB) is an uncommon extrapulmonary manifestation of tuberculosis. Hepatic TB is more common in immunocompromised patients, such as those on immunosuppressive medications or those with a human immunodeficiency virus (HIV) infection. Primary hepatic TB is rare, and liver involvement is often secondary to spreading from the lymphatics, portal vein, or hepatic artery. We report a case of hepatic TB in a patient on adalimumab for ankylosing spondylitis (AS).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211017 | PMC |
| http://dx.doi.org/10.7759/cureus.61264 | DOI Listing |
Publication Analysis
Top Keywords
case hepatic
8
hepatic tuberculosis
8
patient adalimumab
8
adalimumab ankylosing
8
ankylosing spondylitis
8
hepatic
5
tuberculosis patient
4
spondylitis hepatic
4
tuberculosis uncommon
4
uncommon extrapulmonary
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!